Hope is discussed in many literatures and from many perspectives. In this essay hope is discussed from the vantage of psychology and stress and coping theory. Hope and psychological stress share a number of formal properties: both are contextual, meaning-based, and dynamic, and both affect well-being in difficult circumstances. Two assumptions underlie this essay: (1) hope is essential for people who are coping with serious and prolonged psychological stress; and (2) hope is not a perpetually self-renewing resource; it has peaks and valleys and is at times absent altogether. The relationship between hope and coping is dynamic and reciprocal; each in turn supports and is supported by the other. This relationship is illustrated with two adaptive tasks common across situations that threaten physical or psychological well-being-managing uncertainty and coping with a changing reality. The essay describes ways in which coping fosters hope when it is at low ebb as well as ways in which hope fosters and sustains coping over the long term.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/pon.1836 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Designing the next generation of clinical trials in intermediate AMD- a consensus driven, pragmatic, proof of concept early intervention study.
Exp Eye Res
March 2025
Department of Ophthalmology, Duke University, Durham, North Carolina.
A greater understanding of the pathophysiology of AMD has yielded potential therapeutic strategies for slowing vision loss. Structural imaging biomarkers and novel functional outcomes, both under intensive study as surrogate endpoints in AMD clinical trials, are new granular tools needed to assess disease progression and follow response to therapy. These advances have created, for the first time, the possibility to intervene early in AMD, and to measure success in a time frame feasible for clinical trials.
View Article and Find Full Text PDFExploring the Intricacies of Antimicrobial Resistance: Understanding Mechanisms, Overcoming Challenges, and Pioneering Innovative Solutions.
Eur J Pharmacol
March 2025
Department of Pharmacology, Shantou University Medical College, Shantou 515041, China. Electronic address:
Antimicrobial resistance (AMR) poses a growing global threat. This review examines AMR from diverse angles, tracing the story of antibiotic resistance from its origins to today's crisis. It explores the rise of AMR, from its historical roots to the urgent need to counter this escalating menace.
View Article and Find Full Text PDFBackground: Talquetamab is the first GPRC5D × CD3 bispecific antibody approved for relapsed or refractory multiple myeloma. In phase 1 of the MonumenTAL-1 study, initial results of subcutaneous talquetamab 0·4 mg/kg once a week and 0·8 mg/kg every 2 weeks showed preliminary clinical activity. We describe safety and activity results in patients treated with talquetamab, including patients who had received previous T-cell redirection therapy (TCR).
View Article and Find Full Text PDFAI integrations with lung cancer screening: Considerations in developing AI in a public health setting.
Eur J Cancer
March 2025
Mount Sinai Health System, New York, NY, USA. Electronic address:
Lung cancer screening implementation has led to expanded imaging of the chest in older, tobacco-exposed populations. Growing numbers of screening cases are also found to have CT-detectable emphysema or elevated levels of coronary calcium, indicating the presence of coronary artery disease. Early interventions based on these additional findings, especially with coronary calcium, are emerging and follow established protocols.
View Article and Find Full Text PDFAn MR-only deep learning inference model-based dose estimation algorithm for MR-guided adaptive radiation therapy.
Med Phys
March 2025
Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
Background: Magnetic resonance-guided adaptive radiation therapy (MRgART) systems combine Magnetic resonance imaging (MRI) technology with linear accelerators (LINAC) to enhance the precision and efficacy of cancer treatment. These systems enable real-time adjustments of treatment plans based on the latest patient anatomy, creating an urgent need for accurate and rapid dose calculation algorithms. Traditional CT-based dose calculations and ray-tracing (RT) processes are time-consuming and may not be feasible for the online adaptive workflow required in MRgART.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!